There is no cure for primary sclerosing cholangitis; management focuses on symptom relief, slowing disease progression, and, in some cases, liver transplantation
PSC is a chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage. Treatment aims to manage symptoms and complications, with liver transplantation being a potential option in severe cases. Regular monitoring is crucial for assessing liver function, managing symptoms, and addressing potential complications.
Chronic liver disease characterized by inflammation and scarring of the bile ducts
Fatigue, itching, abdominal pain, jaundice
Blood tests, imaging studies
Variable; depends on the progression and response to treatment
Liver failure, complications of untreated primary sclerosing cholangitis
Autoimmune factors, genetic predisposition
Ursodeoxycholic acid (UDCA), medications to manage symptoms, liver transplantation
Ursodeoxycholic acid (UDCA), medications to manage symptoms, liver transplantation
Chronic liver disease affecting the bile ducts
Management aims at slowing disease progression and preventing complications
This information serves as a general overview and does not constitute professional medical advice. Always consult with healthcare providers for accurate and personalized insights regarding your health.
Share: